Pennsylvania Capital Management Inc Athenex, Inc. Transaction History

Pennsylvania Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$2.97 - $4.84 $38,247 - $62,329	-12,878 Closed	0 $0
Q2 2021 Jul 12, 2021	SELL	$3.71 - $5.13 $17,837 - $24,665	-4,808 Reduced 27.19%	12,878 $54,000
Q1 2021 Apr 22, 2021	BUY	$4.08 - $14.75 $18,604 - $67,260	4,560 Added 34.74%	17,686 $76,000
Q3 2020 Oct 07, 2020	BUY	$10.26 - $14.55 $134,672 - $190,983	13,126 New	13,126 $165,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Pennsylvania Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Pennsylvania Capital Management Inc with notifications on news.